Key result
Smoking linked to ~23% higher 36-month mortality in MINOCA patients.
Why the study?
Does current smoking increase mortality and myocardial infarction in patients with MINOCA?
Observational (n=6,045)
Yes
Does current smoking increase mortality and myocardial infarction in patients with MINOCA?
Hazard Ratio: 1.23 (95% CI 1.03–1.47)
Absolute Event Rate: 13.34% vs 16.95%
p-value: p=0.02
While smokers with MINOCA appear to have lower crude mortality due to younger age and fewer comorbidities, smoking is actually an independent risk factor for increased long-term mortality after adjusting for these baseline differences, disproving the 'smoker's paradox'.
Smoking independently raises adjusted 36-month mortality risk in MINOCA; challenges smoker's paradox yet leaves open need for prospective confirmation.
BACKGROUND: The pathomechanism of myocardial infarction with non-obstructive coronary arteries (MINOCA) is diverse and not fully explained. One of the factors for cardiovascular risk evaluation is smoking. Nevertheless, "smoker's paradox" is a controversial phenomenon in patients with myocardial infarction, which can imply better outcomes in smokers than non-smokers. AIMS: This study aimed to assess the association between smoking and clinical outcomes in MINOCA patients. METHODS: In this study 6045 patients hospitalized with a working diagnosis of MINOCA were evaluated, of whom 4808 (79.5%) were non-smokers. Our analysis included baseline characteristics, outcomes, and readmission rates during a 36‑month follow‑up. RESULTS: Smoking patients were significantly younger (59 [52-66] vs. 70 [60-78] years; P <0.001) than non-smokers. There were more male patients in the smoking (64.92% vs. 40.95%) than in the non-smoking group. Smokers were less likely to have traditional risk factors, more frequently had symptoms of angina (89.29% vs. 86.87%; P = 0.03), and had lower mortality during hospitalization (0.81% vs. 1.75%; P = 0.02), after 12 months (8.08% vs. 11.69%; P <0.001) and after 36 months (13.34% vs. 16.95%; P = 0.002), as compared with non-smokers. Nevertheless, multivariable analysis showed that smoking was one of the independent risk factors for 36‑month mortality (hazard ratio, 1.23;95% confidence interval, 1.03-1.47; P = 0.02). CONCLUSIONS: This study showed that lower 36‑month crude rates of death among smokers (comparing to non-smokers) may be explained by a significantly lower burden of traditional risk factors and the younger age of smokers. After adjusting for baseline differences, tobacco use remained an independent risk factor for 36‑month mortality.
No takes yet. Share an insight, caveat, or question.
Koźlik et al. (2026) conducted an observational in Myocardial Infarction with Non-Obstructive Coronary Arteries (MINOCA) (n=6,045). Smoking vs. Non-smokers was evaluated on 36-month all-cause mortality (HR 1.23, 95% CI 1.03-1.47, p=0.02). After adjusting for baseline differences, smoking was an independent risk factor for 36-month mortality (HR 1.23) in patients with myocardial infarction with non-obstructive coronary arteries.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: